The report "Cell Analysis Market by Product & Service (Consumables, Instruments), Technique (Flow Cytometry, PCR, Microscopy), Process (Counting, Viability, Proliferation, Interaction, Single-cell Analysis), End User (Pharma, Biotech) - Global Forecast to 2028", is projected to reach USD 33.9 billion by 2028 from USD 20.2 billion in 2023, at a CAGR of 10.9% during the forecast period.
Download PDF Brochure:
Market Dynamics
Drivers
· Growing preference for cell-based assays in drug discovery
· Increasing funding for cell-based research
· Rising number of drug discovery activities
Restraints
· High cost of instruments and restrictions on reagent use
Opportunities
· High growth potential of single-cell sequencing
· Application scope of novel cell-based assays in cancer research
Challenges
· Standardization of protocols and data integration & quality control for developing cell therapies
Prominent Players:
Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric (US), Merck KGaA (US), Agilent Technologies (US), Olympus Corporation (Japan), Miltenyi Biotec (US), Bio-Rad Laboratories (US), BioStatus Limited (UK), Fluidigm Corporation (US), NanoCellect Biomedical (US), Cell Biolabs (US), Creative Bioarray (US), Meiji Techno (US), Promega Corporation (US), PerkinElmer (US), Tecan Trading AG (Switzerland), CELLINK (US), QIAGEN (Germany), Corning Incorporated (US), 10x Genomics (US), and Illumina (US).
Asia Pacific has registered fastest growth rate during the forecast period in cell analysis market
The global cell analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Rapid increase in the pharmaceutical & biopharmaceutical industries coupled with affordable with cell analysis services are the key contributing factors to the regional growth.
Recent Developments of Cell Analysis Industry
· In 2023, Becton, Dickinson and Company (US) launched a Spectral Cell Sorter that is coupled with high-speed cell imaging. this product combines real-time imaging technology with spectral flow cytometry.
· In 2020, Miltenyi Biotec (Germany) launched MACS GMP Tyto Cartridge, a GMP-compliant cell sorter..
· In 2020, Bio-Rad Laboratories, Inc. (US) acquired Celsee, Inc., a provider of instruments and consumables for the isolation, detection, and analysis of single cells. This acquisition expanded the company’s product offerings in the flow cytometry market.
Commenti